Guest User
Global Sleeping Bruxism Treatment Market Research Report: Information by Type (Primary Bruxism and Secondary Bruxism), Diagnosis (Clinical Examination, X-rays, Electromyographic Methods and Polysomnography), Treatment Type [Dental Approaches (Mouth Guard and NTI-TSS Device) and Medication (Muscle Relaxants, Botox Injections and Anti-anxiety Drugs)], Cause [Obstructive Sleep Apnea, Gastroesophageal Reflux Disease (GERD), Malocclusion and Sleep Paralysis], Patient Type [Pediatric and Adult (Male and Female)], End User (Hospitals and Dental Clinics) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023
Sleep bruxism, which leads to grinding teeth at night, is a condition that can result in disturbed sleep, is an increasingly common condition. Reports that assess the healthcare industry have been presented by Market Research Future, which creates reports on numerous industry verticals that examine the market progress and forecasts. The Sleeping Bruxism Treatment Market Growth is projected to achieve a revenue level of USD 638.22 million while expanding at a CAGR of 6.7 % throughout the forecast period.
The rising pediatric population and altering lifestyles are expected to motivate the sleeping bruxism treatment market globally. The increased accessibility to therapeutic medicines is projected to create an increased impetus for growth in the coming years. The enhanced quality in preventive measures for treating sleeping bruxism is expected to enhance the potential for growth in the approaching period.
Sleeping Bruxism Treatment Market Competitive Analysis
The access to vital planned prospects imperative to the resultant stabilization of inflation is likely to produce a promising option for advancement in the forthcoming years. The growth of the market is influenced by the presence of factors that are stimulating the growth of the market. The need to create a sustainable competitive advantage has accelerated the progress of the market in the forecast period. The diversified consumer tastes and trends in the market are anticipated to lead to an escalated development rate in the market. The use of strategic tools to further the development of the market in the coming years. The competitors have adopted diversified plans to increase their chances for success in the market. The creation of great competitive advantages is expected to aid in the development of the market. A substantial ascent in the number of promoters in the market is anticipated to shape a beneficial state of activities for the growth of the market in the forecasted period.
The significant competitors in the sleeping bruxism treatment market are Pfizer Inc. (U.S.), Ipsen Biopharmaceuticals, Inc. (U.S.), Henry Schein, Inc. (U.S.), Carestream Dental (U.S.), PLANMECA OY (Finland), Akervall Technologies Inc. (U.S.), Merz Pharma GmbH & Co. KGaA (Germany), Randmark Dental Products, LLC (U.S.), S4S Dental Laboratory (U.K.), Patterson Dental Supply, Inc. (U.S.), Ivoclar Vivadent AG (Liechtenstein), and others.
Sleeping Bruxism Treatment Market Segmental Analysis
The segmentation analysis of the Sleeping Bruxism Treatment Market is carried out on the basis of type, diagnosis, treatment type, cause, end user, patient type, and region. On the basis of type, the market for sleeping bruxism treatment has been segmented into secondary and primary bruxism. Based on the diagnosis, the sleeping bruxism treatment market is segmented into polysomnography, electromyographic methods, and x-rays. Based on treatment type, the sleeping bruxism treatment market is segmented into medication and dental approaches. On the basis of cause, the sleeping bruxism treatment market is segmented into obstructive sleep apnea, sleep paralysis, malocclusion, and gastroesophageal reflux disease (GERD). Based on the patient type, the sleeping bruxism treatment market is segmented into adults and pediatrics. Based on end-users, the sleeping bruxism treatment market comprises of dental clinics, hospitals, and others. Based on the regions, the sleeping bruxism treatment market is segmented into Europe, Asia Pacific, the Middle East, the Americas, and Africa.
Sleeping Bruxism Treatment Market Detailed Regional Analysis
The regional evaluation of the sleeping bruxism treatment market comprises of regions such as Europe, Asia Pacific, the Middle East, the Americas, and Africa. The Americas region led the sleeping bruxism treatment market in 2017 by holding 39.1% of the market portion. This is primarily due to the intensifying cases of anxiety and stress-related diseases among the population. The European region is the next chief market. The Asia Pacific region is anticipated to open up options due to its substantial investment in economic growth, healthcare, large population base, and implementation of progressive healthcare technology. Also, dental care and bruxism related awareness is spreading rapidly in nations such as India, Japan, China, and South Korea, which can lift the market’s growth in the forecast period.
